Rongcheng Zhang

1.4k total citations
32 papers, 1.1k citations indexed

About

Rongcheng Zhang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Rongcheng Zhang has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 7 papers in Immunology. Recurrent topics in Rongcheng Zhang's work include Heart Failure Treatment and Management (9 papers), IL-33, ST2, and ILC Pathways (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Rongcheng Zhang is often cited by papers focused on Heart Failure Treatment and Management (9 papers), IL-33, ST2, and ILC Pathways (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Rongcheng Zhang collaborates with scholars based in China, United States and Greece. Rongcheng Zhang's co-authors include Yuhui Zhang, Jian Zhang, Tao An, Mei Zhai, Yan Huang, Yunhong Wang, Cui-Yun Liu, Kun Wang, Yanhan Dong and Lu‐Yu Zhou and has published in prestigious journals such as Nature Communications, PLoS ONE and Advanced Energy Materials.

In The Last Decade

Rongcheng Zhang

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongcheng Zhang China 12 552 423 294 170 115 32 1.1k
Xiao Chuan-shi China 15 321 0.6× 237 0.6× 225 0.8× 121 0.7× 73 0.6× 34 820
Zhonghai Wei China 14 377 0.7× 152 0.4× 286 1.0× 115 0.7× 147 1.3× 43 892
Ningfu Wang China 17 276 0.5× 158 0.4× 243 0.8× 206 1.2× 121 1.1× 47 844
Guoxian Qi China 18 373 0.7× 184 0.4× 259 0.9× 71 0.4× 207 1.8× 75 962
Xiangbo An China 17 390 0.7× 238 0.6× 236 0.8× 72 0.4× 91 0.8× 28 740
Naifeng Liu China 18 377 0.7× 157 0.4× 172 0.6× 72 0.4× 135 1.2× 51 878
Songyan Meng China 10 467 0.8× 151 0.4× 130 0.4× 118 0.7× 84 0.7× 12 718
Giovanna Castoldi Italy 18 416 0.8× 210 0.5× 311 1.1× 79 0.5× 133 1.2× 38 931
Ke‐Qiong Deng China 16 372 0.7× 112 0.3× 249 0.8× 139 0.8× 86 0.7× 32 787
Motoi Kobayashi Japan 15 525 1.0× 213 0.5× 157 0.5× 115 0.7× 123 1.1× 21 1.1k

Countries citing papers authored by Rongcheng Zhang

Since Specialization
Citations

This map shows the geographic impact of Rongcheng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongcheng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongcheng Zhang more than expected).

Fields of papers citing papers by Rongcheng Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongcheng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongcheng Zhang. The network helps show where Rongcheng Zhang may publish in the future.

Co-authorship network of co-authors of Rongcheng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Rongcheng Zhang. A scholar is included among the top collaborators of Rongcheng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongcheng Zhang. Rongcheng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chunyang, Yang Yu, Qi Shen, et al.. (2025). The evolutionary history of the Methyltransf_FA domain and its role in JH signal in silkworm, Bombyx mori. Insect Biochemistry and Molecular Biology. 183. 104375–104375.
2.
Sun, Shiqing, Rongcheng Zhang, Zhenqi Gu, et al.. (2025). Interfacial Stabilization Mechanism of Zirconium‐Based Halide and Li–In Alloy Anode in All‐Solid‐State Lithium Batteries. Advanced Energy Materials. 15(35). 1 indexed citations
3.
Zhang, Rongcheng, Zhongqi Zhang, Di Li, et al.. (2024). REXO2 up-regulation is positively correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. International Immunopharmacology. 130. 111740–111740. 4 indexed citations
4.
Zhang, Zhongqi, et al.. (2024). Predicting colorectal cancer risk: a novel approach using anemia and blood test markers. Frontiers in Oncology. 14. 1347058–1347058. 5 indexed citations
5.
Wang, Yunhao, Wei Yu, Jianxi Wang, et al.. (2023). Low-dose celecoxib-loaded PCL fibers reverse intervertebral disc degeneration by up-regulating CHSY3 expression. Journal of Nanobiotechnology. 21(1). 76–76. 14 indexed citations
6.
Chen, Youfang, et al.. (2023). The m6A methylation enzyme METTL14 regulates myocardial ischemia/reperfusion injury through the Akt/mTOR signaling pathway. Molecular and Cellular Biochemistry. 479(6). 1391–1400. 11 indexed citations
7.
Zhang, Rongcheng, et al.. (2023). Migrasomes and Tetraspanins in Hepatocellular Carcinoma: Current Status and Future Prospects. Future Science OA. 9(9). FSO890–FSO890. 4 indexed citations
8.
Tan, Shengkui, et al.. (2022). hsa-miR-9-5p-Mediated TSPAN9 Downregulation Is Positively Related to Both Poor Hepatocellular Carcinoma Prognosis and the Tumor Immune Infiltration. Journal of Immunology Research. 2022. 1–10. 7 indexed citations
9.
Zhao, Xinke, Rongcheng Zhang, Kai Liu, et al.. (2021). Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure. BMC Endocrine Disorders. 21(1). 140–140. 6 indexed citations
10.
Shi, Changgui, Bin Sun, Huiqiao Wu, et al.. (2020). Dysfunction of Caveolae-Mediated Endocytic TβRI Degradation Results in Hypersensitivity of TGF-β/Smad Signaling in Osteogenesis Imperfecta. Journal of Bone and Mineral Research. 38(1). 103–118. 4 indexed citations
11.
Zhang, Rongcheng, et al.. (2020). Cost-Effectiveness of Adding Dapagliflozin to Standard Treatment for Heart Failure with Reduced Ejection Fraction Patients in China. ESC Heart Failure. 7(6). 3582–3592. 36 indexed citations
12.
13.
Yan, Kaowen, Tao An, Mei Zhai, et al.. (2019). Mitochondrial miR-762 regulates apoptosis and myocardial infarction by impairing ND2. Cell Death and Disease. 10(7). 500–500. 83 indexed citations
14.
Zhou, Lu‐Yu, Mei Zhai, Yan Huang, et al.. (2018). The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/ FAM65B pathway. Cell Death and Differentiation. 26(7). 1299–1315. 213 indexed citations
15.
Long, Bo, Tianyi Gan, Rongcheng Zhang, & Yuhui Zhang. (2017). miR-23a Regulates Cardiomyocyte Apoptosis by Targeting Manganese Superoxide Dismutase. Molecules and Cells. 40(8). 542–549. 50 indexed citations
16.
Zhang, Yuhui, Jian Zhang, Javed Butler, et al.. (2017). Contemporary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results From the China Heart Failure (China-HF) Registry. Journal of Cardiac Failure. 23(12). 868–875. 161 indexed citations
17.
Zhang, Yuhui, Yunhong Wang, Mei Zhai, et al.. (2017). Influence of LGALS3 gene polymorphisms on susceptibility and prognosis of dilated cardiomyopathy in a Northern Han Chinese population. Gene. 642. 293–298. 21 indexed citations
18.
Wang, Yunhong, Yuhui Zhang, Tao An, et al.. (2016). ErbB4 Gene Polymorphism Is Associated With the Risk and Prognosis of Congestive Heart Failure in a Northern Han Chinese Population. Journal of Cardiac Failure. 22(9). 700–709. 4 indexed citations
19.
Lin, Ya-Hui, et al.. (2016). Distribution and clinical association of plasma soluble ST2 during the development of type 2 diabetes. Diabetes Research and Clinical Practice. 118. 140–145. 34 indexed citations
20.
Zhang, Rongcheng, et al.. (2015). [Prevalence and prognostic value of hyponatremia on admission in hospitalized patients with heart failure].. PubMed. 43(10). 868–73. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao Chuan-shi Breakdown of academic impact, for papers by Zhonghai Wei Breakdown of academic impact, for papers by Ningfu Wang Breakdown of academic impact, for papers by Guoxian Qi Breakdown of academic impact, for papers by Xiangbo An Breakdown of academic impact, for papers by Naifeng Liu Breakdown of academic impact, for papers by Songyan Meng Breakdown of academic impact, for papers by Giovanna Castoldi Breakdown of academic impact, for papers by Ke‐Qiong Deng Breakdown of academic impact, for papers by Motoi Kobayashi
Rankless by CCL
2026